Identification of potential dipeptidyl peptidase IV inhibitors from the ConMedNP library by virtual screening, and molecular dynamics methods

• Published in: Heliyon 2024-08, Vol.10 (15), p.e35191, Article e35191
• Main Authors: Tsahnang Fofack, Hans Merlin, Mbah Bake, Maraf, Petry, Simon, Ateba, Baruch A., Amoa Onguéné, Pascal, Mohammad-Salim, Haydar, Ntie-Kang, Fidele, Mbaze, Luc Meva'a, Vakal, Serhii, Kenfack, Cyril A
• Format: Article
• Language: English
• Subjects: ConMedNP library; Dipeptidyl peptidase IV (DPP4); Inhibitors; Molecular dynamics; Virtual screening
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e35191

In this study, we screened novel dipeptidyl peptidase IV (DPP4) inhibitors from the ConMedNP library consisting of 3507 molecules. Interestingly, molecular docking, ADMET, and the anti-diabetic activity predictions suggest that three molecules, namely OTH_UD_XX06_1, GB19, and BMC_000104, have a high binding affinity toward DPP4. The molecular dynamics (MD) simulation results suggest that these hit molecules have a stable binding pose and occupy the binding pockets throughout the 200 ns simulation. The presence of intermolecular H-bonding between the ligands and DPP4 was observed throughout the simulation period. Thus, docking and MD results, predicted that the three compounds were the most potent DPP4 inhibitors that could putatively bind to the DPP4 active site via both conventional H-bonding and hydrophobic interactions. These results could aid the discovery of new drugs to treat type 2 diabetes. [Display omitted]